Home / Aims & Scope
Aims and scope.
What the journal publishes, and the scientific logic of its three sections.
Aims
International Journal of Radiation Medicine — Screening, Surveillance, Survivorship (IJRM-SSS) publishes rigorous, clinically consequential research spanning the full arc of radiation medicine. The journal takes as its organizing premise that ionizing radiation is an immunological as well as a cytotoxic intervention, and that its consequences must be followed from before diagnosis to decades after treatment.
Sections
Screening
- Risk stratification models and interval selection
- Imaging strategy, diagnostic yield, and harms of over-detection
- Immune and molecular signatures of pre-clinical disease
- Radiation exposure from diagnostic and screening programs
Surveillance
- Response assessment and criteria development
- Minimal residual disease and circulating tumor DNA
- Longitudinal immune monitoring during and after therapy
- Distinguishing treatment effect from recurrence
Survivorship
- Late immune effects and persistent lymphopenia
- Second malignancy risk and dose–response
- Cardiovascular, pulmonary, endocrine, and cognitive sequelae
- Patient-reported outcomes over long horizons
Cross-cutting science
Across all three sections, the journal gives priority to work on radiation-induced immunity and immunomodulation: immunogenic cell death, cGAS–STING and interferon signaling, abscopal and out-of-field response, combination with immune checkpoint inhibition and cell therapy, and immune-sparing treatment planning.
Ownership and support
Editorial authority rests with the Editor-in-Chief. Submissions authored by the Institute's founder or leadership are handled entirely externally, without exception.
Out of scope
- Purely technical dosimetry or device engineering without a clinical or biological endpoint
- Single-case reports without a mechanistic or methodological contribution
- Studies with no radiation, immune, or longitudinal-outcome component